Late stent thrombosis 28 months post implantation of a left main coronary drug-eluting stent.

Late stent thrombosis 28 months post implantation of a left main coronary drug-eluting stent.

Detalles Bibliográficos
Main Authors:	Schrale, R, van Gaal, W, Banning, A
Formato:	Journal article
Idioma:	English
Publicado:	2007

Títulos similares

Very Late Stent Thrombosis 42 Months after Implantation of Sirolimus-Eluting Stent and Discontinuation of Antiplatelet Therapy
por: Dirk Sibbing, et al.
Publicado: (2009-01-01)

Incidence, predictors and management of left main coronary artery stent restenosis: a comprehensive review in the era of drug-eluting stents.
por: De Caterina, A, et al.
Publicado: (2013)

Treatment of spontaneous coronary dissection with drug-eluting stents--late clinical, angiographic and IVUS follow up.
por: van Gaal, W, et al.
Publicado: (2006)

Use of a sirolimus-eluting stent to treat failure of a nonpolymer release paclitaxel-eluting stent implanted for in-stent restenosis.
por: Porto, I, et al.
Publicado: (2005)

Everolimus-eluting stents or bypass surgery for left main coronary artery disease.
por: Stone, GW, et al.
Publicado: (2016)

Very late stent thrombosis of Sirolimus-eluting stent 59 months after implantation: A first report from the Middle-East and review of literature
por: Prashanth Panduranga, et al.
Publicado: (2011-01-01)

Association of localized hypersensitivity and in-stent neoatherosclerosis with the very late drug-eluting stent thrombosis.
por: Kyohei Yamaji, et al.
Publicado: (2014-01-01)

Late Thrombosis of Sirolimus-Eluting Stent: A Multifactorial Problem
por: Igor Kranjec, et al.
Publicado: (2009-01-01)

Comparison of the Efficacy of Drug-eluting Stents Versus Bare-metal Stents for the Treatment of Left Main Coronary Artery Disease
por: Xiao-Zeng Wang, et al.
Publicado: (2015-01-01)

Thrombotic occlusion of a drug-eluting stent - is IVUS mandatory.
por: Arnold, JR, et al.
Publicado: (2006)

Case series of coronary artery aneurysms after Everolimus eluting stent implantation and comparison with Sirolimus eluting stents
por: Raghav Sharma, et al.
Publicado: (2022-02-01)

How real is a threat of late thrombosis for drug-eluting stents? Stent comparison and focus on everolimus
por: V. P. Lupanov, et al.
Publicado: (2009-10-01)

Stents versus bypass grafting for left main coronary artery disease.
por: Arnold, JR, et al.
Publicado: (2008)

High platelet reactivity strongly predicts early stent thrombosis in patients with drug-eluting stent implantation
por: Subin Lim, et al.
Publicado: (2024-01-01)

Stent Fracture after Everolimus-Eluting Stent Implantation
por: Ali S. Almasood, et al.
Publicado: (2011-01-01)

Early coronary stent thrombosis after bare metal stent implantation
por: Laxman Dubey, et al.
Publicado: (2014-01-01)

The DELFT (Drug Eluting stent for LeFT main) registry: the unknowns.
por: Taggart, D
Publicado: (2008)

Right coronary artery thrombosis within drug eluting stents more than 10 years after deployment: Two cases of very, very late stent thrombosis
por: Sam Lovibond, et al.
Publicado: (2017-09-01)

A comparison between drug-eluting stent implantation and drug-coated balloon angioplasty in patients with left main bifurcation in-stent restenotic lesions
por: Hyungdon Kook, et al.
Publicado: (2020-02-01)

Usefulness of high-pressure post-dilatation to optimize deployment of drug-eluting stents for the treatment of diffuse in-stent coronary restenosis.
por: Blackman, D, et al.
Publicado: (2004)

Stent thrombosis and bleeding complications after implantation of sirolimus-eluting coronary stents in an unselected worldwide population: a report from the e-SELECT (Multi-Center Post-Market Surveillance) registry.
por: Urban, P, et al.
Publicado: (2011)

Long-term outcomes of percutaneous coronary intervention for unprotected left main coronary artery disease.
por: Schrale, R, et al.
Publicado: (2008)

Drug-Eluting Stent Thrombosis: An oversensationalized but unresolved problem?
por: Azeem Latib, et al.
Publicado: (2016-02-01)

Drug eluting stents in left main stem stenosis: patients will pay the price.
por: Taggart, D
Publicado: (2007)

Coronary In-Stent Restenosis Predictors following Drug-Eluting Stent Implantation: A Meta-Analysis Study
por: Mohammad Saifur Rohman, et al.
Publicado: (2023-07-01)

Second Generation Drug-Eluting Stent Implantation versus Coronary Artery Bypass Grafting in the Treatment of Young Patients with Left Main and/or Multivessel Coronary Disease
por: Xue Chen, et al.
Publicado: (2020-01-01)

Diabetic and nondiabetic patients with left main and/or 3-vessel coronary artery disease: comparison of outcomes with cardiac surgery and paclitaxel-eluting stents.
por: Banning, A, et al.
Publicado: (2010)

Acute Coronary Syndrome after 17 Years of Bare Metal Stent Implantation: “Very” Very Late Stent Thrombosis
por: Raghavendra Rao K, et al.
Publicado: (2020-01-01)

Safety of MRI early after implantation of a drug-eluting stent.
por: Porto, I, et al.
Publicado: (2004)

Atherosclerotic plaque behind the stent changes after bare-metal and drug-eluting stent implantation in humans: Implications for late stent failure?
por: Takahashi, Saeko, et al.
Publicado: (2017)

The Twelve-Month Outcome of Biolimus Eluting Stent with Biodegradable Polymer Compared With an Everolimus Eluting Stent with Durable Polymer
por: Ahmad Separham, et al.
Publicado: (2011-11-01)

Intravascular ultrasound imaging in the diagnosis and treatment of spontaneous coronary dissection with drug-eluting stents.
por: Porto, I, et al.
Publicado: (2004)

Clinical results of everolimus-eluting stents and sirolimus-eluting stents in patients undergoing percutaneous coronary intervention
por: Iraj Jafaripour, et al.
Publicado: (2023-05-01)

Calcified nodule progression-related stent thrombosis after polymer-based paclitaxel-eluting nitinol stent implantation for femoropopliteal artery
por: Tatsuya Nakama, MD, et al.
Publicado: (2021-09-01)

Attempted retrograde reopening of an occluded left main stent.
por: Niccoli, G, et al.
Publicado: (2002)

Evolving management of patients treated by drug-eluting stent: prevention of late events.
por: Niccoli, G, et al.
Publicado: (2014)

Evolving management of patients treated by drug-eluting stent: Prevention of late events
por: Niccoli, G, et al.
Publicado: (2014)

Effectiveness of Two-Year Versus One-Year Use of Dual Antiplatelet Therapy in Reducing the Risk of Very Late Stent Thrombosis After Drug-Eluting Stent Implantation
por: Ali Reza Amirzadegan, et al.
Publicado: (2012-06-01)

Effectiveness of Two-Year versus One-Year Use of Dual Antiplatelet Therapy in Reducing the Risk of Very Late Stent Thrombosis after Drug-Eluting Stent Implantation
por: Hamid Reza Poorhosseini, et al.
Publicado: (2012-04-01)

Subacute Drug-Eluting Stent Thrombosis Caused by Stent Underexpansion: Evaluation by Optical Coherence Tomography
por: Roberto Martín-Reyes, et al.
Publicado: (2011-01-01)